Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures

Takahiro Niikura, David J. Hak, A Hari Reddi

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Nonunion is a challenging problem that may occur following certain bone fractures. However, here has been little investigation of the molecular basis of nonunions. Bone morphogenetic proteins (BMPs) play a significant role in osteogenesis. However, little is known about the expression patterns of BMPs in abnormal bone healing that results in nonunion formation. These facts prompted us to investigate and compare the gene expression patterns of BMPs and their antagonists in standard healing fractures and nonunions using rat experimental models. Standard closed healing fractures and experimental atrophic nonunions produced by periosteal cauterization at the fracture site were created in rat femurs. At postfracture days 3, 7, 10, 14, 21, and 28, total RNA was extracted from the callus of standard healing fracture and fibrous tissue of nonunion (n = 4 per each time point and each group). Gene expression of BMPs, BMP antagonists, and other regulatory molecules were studied by methods including Genechip® microarray and real-time quantitative RT-PCR. Gene expression of BMP-2, 3, 3B, 4, 6, 7, GDF-5, 7, and BMP antagonists noggin, drm, screlostin, and BAMBI were significantly lower in nonunions compared to standard healing fractures at several time points. Downregulation in expression of osteogenic BMPs may account for the nonunions of fracture. The balance between BMPs and their endogenous antagonists is critical for optimal fracture healing.

Original languageEnglish (US)
Pages (from-to)1463-1471
Number of pages9
JournalJournal of Orthopaedic Research
Volume24
Issue number7
DOIs
StatePublished - Jul 2006

Fingerprint

Bone Morphogenetic Proteins
Fracture Healing
Down-Regulation
Gene Expression
Genes
Bone Morphogenetic Protein 3
Growth Differentiation Factor 5
Bone Morphogenetic Protein 7
Closed Fractures
Cautery
Bone Morphogenetic Protein 2
Bone Fractures
Bony Callus
Osteogenesis
Femur
Real-Time Polymerase Chain Reaction
Theoretical Models
RNA
Bone and Bones

Keywords

  • BMP antagonists
  • Bone morphogenetic proteins
  • Fracture healing
  • Gene expression
  • Nonunion

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. / Niikura, Takahiro; Hak, David J.; Reddi, A Hari.

In: Journal of Orthopaedic Research, Vol. 24, No. 7, 07.2006, p. 1463-1471.

Research output: Contribution to journalArticle

@article{aaa88d6783984c89a30523cb4629f3c3,
title = "Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures",
abstract = "Nonunion is a challenging problem that may occur following certain bone fractures. However, here has been little investigation of the molecular basis of nonunions. Bone morphogenetic proteins (BMPs) play a significant role in osteogenesis. However, little is known about the expression patterns of BMPs in abnormal bone healing that results in nonunion formation. These facts prompted us to investigate and compare the gene expression patterns of BMPs and their antagonists in standard healing fractures and nonunions using rat experimental models. Standard closed healing fractures and experimental atrophic nonunions produced by periosteal cauterization at the fracture site were created in rat femurs. At postfracture days 3, 7, 10, 14, 21, and 28, total RNA was extracted from the callus of standard healing fracture and fibrous tissue of nonunion (n = 4 per each time point and each group). Gene expression of BMPs, BMP antagonists, and other regulatory molecules were studied by methods including Genechip{\circledR} microarray and real-time quantitative RT-PCR. Gene expression of BMP-2, 3, 3B, 4, 6, 7, GDF-5, 7, and BMP antagonists noggin, drm, screlostin, and BAMBI were significantly lower in nonunions compared to standard healing fractures at several time points. Downregulation in expression of osteogenic BMPs may account for the nonunions of fracture. The balance between BMPs and their endogenous antagonists is critical for optimal fracture healing.",
keywords = "BMP antagonists, Bone morphogenetic proteins, Fracture healing, Gene expression, Nonunion",
author = "Takahiro Niikura and Hak, {David J.} and Reddi, {A Hari}",
year = "2006",
month = "7",
doi = "10.1002/jor.20182",
language = "English (US)",
volume = "24",
pages = "1463--1471",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures

AU - Niikura, Takahiro

AU - Hak, David J.

AU - Reddi, A Hari

PY - 2006/7

Y1 - 2006/7

N2 - Nonunion is a challenging problem that may occur following certain bone fractures. However, here has been little investigation of the molecular basis of nonunions. Bone morphogenetic proteins (BMPs) play a significant role in osteogenesis. However, little is known about the expression patterns of BMPs in abnormal bone healing that results in nonunion formation. These facts prompted us to investigate and compare the gene expression patterns of BMPs and their antagonists in standard healing fractures and nonunions using rat experimental models. Standard closed healing fractures and experimental atrophic nonunions produced by periosteal cauterization at the fracture site were created in rat femurs. At postfracture days 3, 7, 10, 14, 21, and 28, total RNA was extracted from the callus of standard healing fracture and fibrous tissue of nonunion (n = 4 per each time point and each group). Gene expression of BMPs, BMP antagonists, and other regulatory molecules were studied by methods including Genechip® microarray and real-time quantitative RT-PCR. Gene expression of BMP-2, 3, 3B, 4, 6, 7, GDF-5, 7, and BMP antagonists noggin, drm, screlostin, and BAMBI were significantly lower in nonunions compared to standard healing fractures at several time points. Downregulation in expression of osteogenic BMPs may account for the nonunions of fracture. The balance between BMPs and their endogenous antagonists is critical for optimal fracture healing.

AB - Nonunion is a challenging problem that may occur following certain bone fractures. However, here has been little investigation of the molecular basis of nonunions. Bone morphogenetic proteins (BMPs) play a significant role in osteogenesis. However, little is known about the expression patterns of BMPs in abnormal bone healing that results in nonunion formation. These facts prompted us to investigate and compare the gene expression patterns of BMPs and their antagonists in standard healing fractures and nonunions using rat experimental models. Standard closed healing fractures and experimental atrophic nonunions produced by periosteal cauterization at the fracture site were created in rat femurs. At postfracture days 3, 7, 10, 14, 21, and 28, total RNA was extracted from the callus of standard healing fracture and fibrous tissue of nonunion (n = 4 per each time point and each group). Gene expression of BMPs, BMP antagonists, and other regulatory molecules were studied by methods including Genechip® microarray and real-time quantitative RT-PCR. Gene expression of BMP-2, 3, 3B, 4, 6, 7, GDF-5, 7, and BMP antagonists noggin, drm, screlostin, and BAMBI were significantly lower in nonunions compared to standard healing fractures at several time points. Downregulation in expression of osteogenic BMPs may account for the nonunions of fracture. The balance between BMPs and their endogenous antagonists is critical for optimal fracture healing.

KW - BMP antagonists

KW - Bone morphogenetic proteins

KW - Fracture healing

KW - Gene expression

KW - Nonunion

UR - http://www.scopus.com/inward/record.url?scp=33746134510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746134510&partnerID=8YFLogxK

U2 - 10.1002/jor.20182

DO - 10.1002/jor.20182

M3 - Article

VL - 24

SP - 1463

EP - 1471

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 7

ER -